Laboratorios Farmaceuticos ROVI (ROVI)

Madrid
Currency in EUR
52.750
+0.350(+0.67%)
Closed·
ROVI Scorecard
Full Analysis
Stock generally trades with low price volatility
ROVI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
52.40052.950
52 wk Range
45.52094.800
Key Statistics
Edit
Bid/Ask
52.30 / 53.40
Prev. Close
52.75
Open
52.6
Day's Range
52.4-52.95
52 wk Range
45.52-94.8
Volume
46.49K
Average Vol. (3m)
101.49K
1-Year Change
-38.91%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ROVI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
80.013
Upside
+51.68%
Members' Sentiments
Bearish
Bullish
ProTips
Cash flows can sufficiently cover interest payments
Show more

Laboratorios Farmaceuticos ROVI Company Profile

Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It also provides hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express; catheter care under the Fibrilin brand; and Sodium Heparin Rovi. In addition, the company offers contract-manufacturing services comprising compounding, aseptic filling and terminal sterilisation, inspection, installation of safety devices, labelling, packaging, serialisation and aggregation, for different injectable pharmaceutical forms, such as prefilled syringes, vials and cartridges, as well as manufacturing and packaging services for solid products. Its products are used for cardiology, osteoarticular/women’s health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

Employees
2197
Market
Spain

Compare ROVI to Peers and Sector

Metrics to compare
ROVI
Peers
Sector
Relationship
P/E Ratio
0.0x17.7x−0.5x
PEG Ratio
0.000.110.00
Price / Book
0.0x1.8x2.6x
Price / LTM Sales
0.0x1.9x3.0x
Upside (Analyst Target)
0.0%39.1%54.1%
Fair Value Upside
Unlock24.1%8.7%Unlock

Analyst Ratings

6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 80.013
(+51.68% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.74%
Dividend Yield
1.44%
Industry Median 0.85%
Annualized Payout
0.76
Paid annually
5-Years Growth
+39.80%
Growth Streak

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-- / --
Revenue / Forecast
155.00M / --
EPS Revisions
Last 90 days

People Also Watch

2.82
GEST
-2.02%
1.916
UNI
+0.63%
62.800
VIS
+0.96%
16.72
PUIGb
+0.06%
28.62
LOG
+1.06%

FAQ

What Is the Laborat.Rovi (ROVI) Stock Price Today?

The Laborat.Rovi stock price today is 52.75

What Stock Exchange Does Laborat.Rovi Trade On?

Laborat.Rovi is listed and trades on the Madrid Stock Exchange stock exchange.

What Is the Stock Symbol for Laborat.Rovi?

The stock symbol for Laborat.Rovi is "ROVI."

Does Laborat.Rovi Pay Dividends? What’s The Current Dividend Yield?

The Laborat.Rovi dividend yield is 1.44%.

What Is the Laborat.Rovi Market Cap?

As of today, Laborat.Rovi market cap is 2.70B.

What Is Laborat.Rovi's Earnings Per Share (TTM)?

The Laborat.Rovi EPS (TTM) is 2.74.

When Is the Next Laborat.Rovi Earnings Date?

Laborat.Rovi will release its next earnings report on Jul 23, 2025.

From a Technical Analysis Perspective, Is ROVI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.